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Background: The perinatal period is one in which the mammalian brain is particularly vulnerable to immune-mediated
damage. Early inflammation in the central nervous system (CNS) is linked with long-term impairment in learning and
behavior, necessitating a better understanding of mediators of neuroinflammation. We therefore directly examined
how age affected neuroinflammatory responses to pathogenic stimuli.
Methods: In mice, susceptibility to neurological damage changes dramatically during the first few weeks of life.
Accordingly, we compared neuroinflammatory responses to pathogen associated molecular patterns (PAMPs) of neonatal
(two day-old) and weanling (21 day-old) mice. Mice were inoculated intracerebrally with PAMPs and the cellular and
molecular changes in the neuroinflammatory response were examined.
Results: Of the 12 cytokines detected in the CNS following toll-like receptor 4 (TLR4) stimulation, ten were significantly
higher in neonates compared with weanling mice. A similar pattern of increased cytokines in neonates was also observed
with TLR9 stimulation. Analysis of cellular responses indicated a difference in microglial activation markers in the CNS
of neonatal mice and increased expression of proteins known to modulate cellular activation including CD11a, F4/80
and CD172a. We also identified a new marker on microglia, SLAMF7, which was expressed at higher levels in neonates
compared with weanlings.
Conclusions: A unique neuroinflammatory profile, including higher expression of several proinflammatory cytokines and
differential expression of microglial markers, was observed in brain tissue from neonates following TLR stimulation. This
increased neuroinflammatory response to PAMPs may explain why the developing brain is particularly sensitive to
infection and why infection or stress during this time can lead to long-term damage in the CNS.Background
During the perinatal period, the mammalian brain is de-
veloping rapidly and is particularly sensitive to inflam-
mation or maternal stress. Gestational viral, bacterial
and parasitic infections have been linked to neurological
illnesses in offspring, including cerebral palsy and
schizophrenia [1-3]. Additionally, perinatal infection is a
factor for developing neurodegenerative diseases such as
Alzheimer’s and Parkinson’s later in life [4-6]. Current
research suggests that it may not be the infectious agent
per se but the immune response that is causing the
neurological damage [2,7,8]. One useful model is the* Correspondence: petersonka@niaid.nih.gov
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article, unless otherwise stated.neonatal mouse, where cortical development roughly
corresponds to the human fetus midway through gesta-
tion [9,10]. Neonatal rodent models have demonstrated
that perinatal immune stimulation with either infectious
agents or Toll-like receptor (TLR) ligands can produce
developmental and behavioral changes similar to those
observed in human neurological illnesses, including al-
terations in learning and memory [8,11]. Understanding
the immune response in the CNS during the perinatal
period is necessary in order to understand how develop-
mental abnormalities and neurological damage may
occur.
Studies of immune cells in neonates indicate that the
peripheral immune response is often suppressed in re-
sponse to infection or immune stimuli [12-15]. As such,
neonates and infants are more susceptible to viral andntral Ltd. This is an Open Access article distributed under the terms of the
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, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Christensen et al. Journal of Neuroinflammation 2014, 11:70 Page 2 of 13
http://www.jneuroinflammation.com/content/11/1/70bacterial infections compared with adults [12,16,17].
This suppression may be due in part to reduced activa-
tion of neonatal monocytes to TLR activation compared
with adult monocytes [13-15,18,19]. Inability to respond
to viral or bacterial infections may allow infections to
spread and persist in the neonatal host, resulting in in-
creased damage to healthy tissues compared with adults.
It is unclear whether the suppressed immune response
observed in the periphery of neonates during develop-
ment is also observed in the CNS. During development,
microglial cells, which are considered to be the resident
macrophage population of the brain, are in an active
state [20-22]. Microglia are derived from the yolk sac
and migrate into the CNS during the perinatal period
where they are actively involved in pruning synapses
from neurons [22,23]. Following this process, microglia
undergo a ramification process where they become qui-
escent and persist in this state unless activated by insult
or injury [20]. Thus, microglia may actually be more ac-
tivated, and thus possibly more responsive to immune
stimuli, during the perinatal/neonatal period compared
with adults.
Here we have examined neuroinflammatory responses
in neonatal and weanling mice by inoculating them with
two pathogen associated molecular patterns (PAMPs)
that have been used for modeling neurodevelopmental
illness: lipopolysaccharide (LPS), the ligand for TLR4,
and unmethylated CpG oligodeoxynucleotides (CpG-
ODN), the ligand for TLR9. Increased expression of pro-
inflammatory cytokines and chemokines, as well as other
neuroinflammatory markers, were significantly elevated
in the brains of neonatal mice compared with weanling
mice. We then examined the myeloid cell population




All animal research was carried out in adherence with
protocols approved by the National Institutes of Health
Rocky Mountain Laboratories Animal Care and Use
Committee with animal protocols 2008-46 and 2009-70.
Animal models and inoculation of TLR agonists
All mice were housed and maintained by the Rocky
Mountain Laboratories Veterinary Branch (Hamilton,
MT, USA). Mice were maintained under pathogen-free
conditions with regular light/dark cycles and given food
and water ad libitum. For inoculations, neonatal (two day-
old) C57BL/10 mice were anaesthetized by hypothermia,
while weanling (21 day-old) mice were anaesthetized by
isofluorane inhalation prior to inoculation. Mice were in-
oculated intracerebrally (ic), using a Hamilton syringe with
a 33-gauge needle, once in each hemisphere with asolution volume of 3 μl per hemisphere. Mice were inocu-
lated with either LPS, CpG-ODN or as an inoculation
control, PBS. We used LPS and CpG-ODN concentrations
that, based on preliminary studies, were expected to elicit
strong TLR-mediated responses without being lethal. Mice
were inoculated with either 0.5 μg LPS per gram of body
weight or 0.125 μg CpG-ODN per gram of body weight.
For neonatal mice, this meant a total inoculum of 1 μg of
LPS or 0.25 μg (40 picomoles) of CpG-ODN. For three
week old mice, this translated to 3.8 μg of LPS or 0.95 μg
of CpG-ODN. Uninoculated mice were also used as add-
itional controls. To control for any possible variations
between litters, agonist preparation or inoculations, all ex-
perimental groups contained mice from different litters
that were inoculated on different days.
At the indicated time points, all animals were anaes-
thetized by inhalation of isofluorane and euthanized
using axillary incision. Brain tissue was snap frozen in
liquid nitrogen and stored at −80°C until use.
TLR agonists
TLR4 agonist ultra-pure LPS (catalog number tlrl-
3pelps) and TLR9 agonist phosphorothioated CpG-ODN
type B [5′-tcc atg acg ttc ctg acg tt-3′] (catalog number
tlrl-1826) were purchased from InvivoGen (San Diego,
CA, USA). Agonist stocks were suspended in endotoxin-
free water, aliquoted and stored at −20°C. Immediately
prior to use, agonists were diluted in endotoxin-free,
PBS-buffered solution.
Protein quantification
For protein quantification, brain tissue was weighed and
homogenized in Bio-Plex cell lysis buffer (Bio-Rad,
Hercules, CA, USA; catalog number 171-304012) contain-
ing PMSF (Sigma, St. Louis, MO, USA; catalog number
P-7626) and Complete Mini Protease Inhibitor Cocktail
(Roche, Basel, CH; catalog number 11836153001) as previ-
ously described [24]. All samples were diluted to a final
concentration of 300 mg/ml of brain tissue in lysis buffer.
Samples were then centrifuged at 4,500 × g for 15 minutes
at 4°C to remove debris. Cytokine and chemokine protein
levels in brain homogenate supernatants were analyzed
using the Invitrogen Mouse Cytokine Twenty-Plex
Antibody Bead kit (Carlsbad, CA, USA; catalog number
LMC006) on a Bio-Rad Bio-Plex 200 system (Hercules,
CA, USA). Individual protein concentrations were calcu-
lated using standard curves generated from standards
provided with the Twenty-Plex kit.
Quantification of mRNA expression by real-time PCR
Total RNA was extracted from brain tissue using the
Qiagen RNeasy Mini Kit (Valencia, CA, USA; catalog
number 74106) per the manufacturer’s instructions.
RNA was then treated with DNase (Ambion, Foster City,
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37°C, followed by a final purification and concentration
using the Zymo Research RNA Clean-up kit (catalog
number R1018). Complimentary DNA (cDNA) was gen-
erated from the isolated RNA using the iScript cDNA
Synthesis kit (Bio-Rad, Hercules, CA, USA; catalog num-
ber 170-8891). All primers were designed using Primer3
and were gene-specific in blast searches performed using
the National Center for Biotechnology Information data-
base as previously described [24]. Real-time PCR was
performed using iTAQ SYBR Green Supermix with
ROX (Bio-Rad, Hercules, CA, USA, catalog number
1725852) on an Applied Biosystems (Grand Island, NY,
USA) PRISM 7900HT instrument. All samples were run
in triplicate. The baseline was automatically set and the
CT was manually set to intersect the mid-log phase of
PCR curves at 0.19. Dissociation curves were used to
verify that only a single gene product was amplified in
each sample. Data analysis was completed following the
published criteria for real-time quantitative PCR method
using the comparative CT method [25,26]. Gene expres-
sion was calculated relative to the average expression of
three housekeeping genes (Actb, Gusb, Rpl32) for each
sample within an experiment. The same housekeeping
genes were used for each experiment. Data are shown as
the percent of the average of the housekeeping genes
(% of housekeeping genes). RNA that was not reverse
transcribed and water were used as negative controls.
Preparation of brain tissue for flow cytometry
Animals were anaesthetized by inhalation of isofluorane,
followed by perfusion through the left ventricle of the heart
with ice cold 1× Hank’s balanced salt solution (HBSS) with-
out calcium and magnesium (Gibco, Grand Island, NY,
USA; catalog number 14185). Whole brains were removed
and sliced into several pieces prior to homogenization with
a Dounce homogenizer and/or trituration using a 5 ml pi-
pet. Samples were further triturated using a 20-gauge needle.
For some experiments, brain homogenates were further dis-
sociated by incubation in 0.05% Collagenase D (Roche,
Basel, CH; catalog number 11 088 882 001), 0.09 U/ml Dis-
pase I (Sigma, St. Louis, MO, USA; catalog number D4818)
and 0.025 U/ml DNase I (Sigma, catalog number D4527) in
1× HBSS at room temperature for 30 minutes with continu-
ous rocking. To isolate the myeloid and immune cells, cells
were resuspended in 70% Percoll/HBSS and fractionated
using a Percoll gradient as previously described [27]. Cells
were harvested from the 30/70% interface of the Percoll gra-
dient, washed in HBSS and analyzed by flow cytometry or
used for quantitative real-time PCR.
Flow cytometric analysis of CNS populations ex vivo
Following isolation by Percoll gradient, samples were
plated onto 96-well plates and analyzed for cell surfacemarkers as previously described [28]. In short, cells were
fixed in 2% paraformaldehyde, then permeabilized in
0.1% saponin/2% BSA/1× PBS. Samples were incubated
in an FC blocking solution containing rat anti-mouse
CD16/CD32 Fcγ III/II antibody (BD Pharmingen, San
Diego, CA, USA; catalog number 553142) in 2% donkey
serum/0.1% saponin/2% BSA/1× PBS. Cells were incu-
bated with fluorochrome-conjugated antibodies at room
temperature. After washing twice, cells were resuspended
in PBS and analyzed on a FACSAria flow cytometer (BD
Biosciences, San Jose, CA, USA) using FACSDiva software
(BD Biosciences, San Jose, CA, USA). Cells were gated as
described in the figure legends.
Results
Neuroinflammatory responses are increased in neonates
compared with weanling mice
To determine if the neuroinflammatory response changes
in the first weeks of life, we inoculated neonatal (two day-
old) and weanling (21 day-old) mice ic with either the
TLR4 agonist, LPS, or the TLR9 agonist, CpG-ODNs.
Control mice were inoculated with vehicle controls.
Cytokine protein levels were examined at 12 hours
post inoculation (hpi), a time point previously shown to
be the peak of cytokine production following TLR ligand
inoculation in the CNS [29,30]. Twelve cytokines were
detectable at significant levels following TLR stimulation
of the CNS. Several of these cytokines, including IL-1α,
IL-1β, IL-2, IL-5, IL-6, TNF, CC chemokine ligand (CCL)
2, CCL3 and CXCL9 were significantly higher in neo-
natal brain tissue than in weanling brain tissue in
response to LPS (Figure 1). CpG-ODN also induced
higher responses in neonates than in weanling mice for
IL-2, IL-5, TNF, CCL2 and CXCL9. No significant age-
dependent differences were observed for IL-12 or
CXCL1. The cytokines tested were undetectable at later
time points of 24, 48 or 72 hours for both neonates and
weanling mice. Overall, the levels of several cytokines in-
duced by TLR4 and/or TLR9 ligand induction were sig-
nificantly higher in neonates than those observed in
weanlings.
Since a difference in the expression of several cyto-
kines was observed between weanling and neonates, we
further examined neuroinflammatory responses using
real-time PCR analysis. RNA was analyzed at 6 hpi, a
timepoint that correlates with peak mRNA expression of
cytokines following TLR stimulation both in vitro and
in vivo [28,30]. Analysis of mRNA expression also indi-
cated similarly increased levels of several of these cyto-
kines in neonatal mice as well as increased expression of
inducible nitric oxide (Nos2, iNos) mRNA and adhesion
molecule Icam1 mRNA (Figure 2, data not shown). In
contrast, expression of Csf2 (GM-CSF) mRNA, a growth
factor for monocytes, was elevated in brain tissue from
































































































































































































Figure 1 Heightened neonatal cytokine responses in the CNS following TLR4 and TLR9 stimulation. Neonatal (gray bars) and weanling
(open bars) mice were inoculated intracerebrally (ic) with LPS or CpG-ODN at the concentrations described in the Methods section. Control
groups were either not inoculated (none) or inoculated ic with PBS. At 12 hpi, brain tissue was removed and processed for protein analysis.
Cytokine protein levels in brain homogenates from neonatal and weanling mice were measured using a Multiplex bead assay. n = 10 to 12 for
neonates and 5 to 6 for weanling mice. Data are presented as mean ± SEM. Statistical analysis was completed by two-way analysis of variance
with Sidak’s multiple comparisons test. Significant age-specific differences are as indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
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Thus, LPS inoculation induced different neuroinflamma-
tory responses in neonates compared with weanlings
with increased production of several cytokines and de-





























Figure 2 Increased mRNA expression of inflammatory markers in neo
was used to analyze the expression of neuroinflammatory markers in brain
expression of Nos2 (iNos) (A) and Icam1 (B) mRNAs were observed in brain
(C) was elevated in brain tissue from LPS-inoculated weanling mice. n = 4 m
was completed by two-way analysis of variance with Tukey’s multiple com
are indicated in the figure as: ***P < 0.001.To examine the time course of these neuroinflamma-
tory responses, we measured mRNA expression levels
from 2 to 48 hpi after treatment with either LPS or ve-
hicle control. Modest increases in gene expression for









natal brain tissue following LPS stimulation. Real-time PCR analysis
tissue from neonatal and weanling mice at 6 hpi. Increased mRNA
tissue from LPS-inoculated neonatal mice, while Csf2 (GMCSF) mRNA
ice per group. Data are presented as mean ± SEM. Statistical analysis
parisons test. Significant age-specific differences in the LPS response
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2 hpi but not at other time points. At 2 hpi after stimu-
lation with LPS, Ccl2 and Il6 mRNA levels were compar-
able between the two ages, while Ccl3 mRNA was
higher in neonates (Figure 3). However, by 6 hpi, these
LPS responses in weanling mice had dropped to nearly
basal levels while neonatal Il6 and Ccl2 levels remained
elevated (Figure 3). Thus, expression of certain cytokine
mRNAs were generally higher in neonates and peak ex-
pression occurred later than that observed in weanlings.
This difference in kinetics may contribute to the in-
creased protein levels of these cytokines observed at 12
hpi (Figure 1).
One possible explanation for the increased neuroin-
flammatory responses in neonatal mice would be higher
expression of TLRs in the brains of neonates than adult
mice. However, analysis of mRNA demonstrated lower
levels of Tlr4 and Tlr9 mRNA in neonatal brain com-
pared with other ages (Figure 4). Thus, the increased
neuroinflammatory response is not likely to be due to
increased expression of TLRs in the neonatal brain.
Differences in immune cell markers between neonates
and weanlings
To investigate which cell types might be contributing to
the heightened neonatal inflammatory response, we
compared mRNA expression levels of inflammatory cells
and glial cells in brain tissue from neonatal and weanling
mice. Analysis of gene expression for inflammatory cells
including T cells (Cd3ε, Cd8α) and neutrophils (Ela2)
showed that these genes were only induced at 12 to 48
hpi (Figure 5A-C), after the peak cytokine response
(Figure 3). Thus, an influx of T cells or neutrophils
would probably be responding to, rather than producing,
early increases in cytokine levels. The level of mRNA for
the astrocyte activation marker Gfap was lower in neo-

































Figure 3 Time course analyses of cytokine mRNA expression indicate
and weanlings. Cytokine mRNA levels in brains from neonatal and weanli
with PBS or LPS. n = 4 to 6 mice per group per time point from combined
was completed by two-way analysis of variance with Tukey’s multiple com
between neonates and weanlings are indicated: **P < 0.01, ***P < 0.001.that more activated astrocytes were also not likely to be
the source of heightened cytokine responses in neonates.
However, mRNAs for activation markers of myeloid cells
(for example, microglia and macrophages), namely Itgax
(Cd11c) and Cd80, were elevated at 6 to 12 hpi in neo-
nates compared with weanlings (Figure 5E-F), in concert
with the increases in the various cytokine mRNAs. Inter-
estingly, at these time points we also observed elevated
mRNA levels for Slamf7 (Figure 5G), whose expression
has been reported on natural killer (NK) cells and other
immune cells [31,32]. Thus, the only cell markers that
correlated with the early neuroinflammatory response in
neonates were those thought to be primarily for myeloid
cells and/or NK cells.
Myeloid cells from brain tissue of neonatal mice have
heightened responses to LPS stimulation
Since resident myeloid cells and/or inflammatory cells
such as NK cells could be contributing to the cytokine
response, we isolated these cells from the brains of neo-
natal and weanling mice using a Percoll gradient. The 6
hpi time point was used to allow for RNA analysis of
isolated cell fractions. We analyzed cells from the 30/
70% interface, which are predominantly microglia, mac-
rophages and infiltrating immune cells [33]. Analysis of
this cell fraction for CD4+ T cells, CD8+ T cells, NK
cells and B cells indicated no significant populations of
these cells in the brain for either neonatal or weanling
mice (data not shown). Instead, the primary cells in
this fraction for both neonates and weanling mice
were CD45+ CD11b +myeloid cells; primarily microglia,
monocytes and resident macrophages (data not shown).
RNA analysis of the myeloid cell fraction for genes an-
alyzed in whole brain fractions demonstrated greater up-
regulation of Ccl2, Nos2 and Slamf7 mRNA following
LPS stimulation in neonates compared with weanlings

















differences in the brain cytokine response between neonates
ng mice were assayed at 2, 6, 12 and 48 hpi following ic inoculation
experiments. Data are presented as mean ± SEM. Statistical analysis































Figure 4 Tlr4 and Tlr9 mRNA expression is influenced by age. Tlr4 (A) and Tlr9 (B) mRNA levels were measured in the brains from untreated
neonatal and weanling mice. Housekeeping gene expression was averaged using Gusb, Actb and Rpl32. Data are presented as mean ± SEM















































































































Figure 5 Temporal expression of glial and immune cell markers after TLR4 stimulation. Brains from neonatal and weanling mice
(described in Figure 3) were analyzed for (A-G) inflammatory cell markers as well as astrocytic and myeloid cell markers. An increase in T cell
markers Cd3ε (A) and Cd8α (B), as well as neutrophil marker Ela2 (C) was not observed until 12 to 48 hours post infection. Gfap (D) mRNA
was upregulated at 6 to 12 hours post infection with higher levels in weanling mice. In contrast, myeloid markers Itgax (E) and Cd80 (F) were
higher in neonates than weanlings. Slamf7 (G), which is expressed by a number of immune cells, was also elevated in neonates compared with
weanlings. Black symbols indicate data from LPS-stimulated mice, while gray symbols indicate PBS-treated controls. n = 4 to 6 mice per group per
time point from combined experiments. Data are presented as mean ± SEM. Statistical analysis was completed by two-way analysis of variance
with Tukey’s multiple comparisons test. Significant age-specific differences in the LPS response are as indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 6 Neonatal versus weanling expression of neuroinflammatory genes in myeloid cells isolated from the CNS. At six hours after
ic inoculation with PBS or LPS, brain homogenates from neonatal and weanling mice were fractionated on Percoll gradients, and mRNA expression
levels were analyzed by qRT-PCR. mRNA expression of neuroinflammatory markers Ccl2 (A), Nos2 (B) and Slamf7 (C) were elevated in the myeloid
fraction from LPS-inoculated neonatal mice. Il6 (D) and Tlr4 (E) mRNA were not significantly different between age groups, while Tlr9 (F) mRNA levels
were increased in myeloid cells from weanling mice. n = 4 to 5 mice per group from combined experiments. Data are presented as mean ± SEM.
Statistical analysis was completed by two-way analysis of variance with Tukey’s multiple comparisons test. Significant age-specific-differences in the
response to LPS are shown: ***P < 0.001.
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brain tissue (Figure 3) were not significantly different in
the myeloid cell fractions at this time point (Figure 6D).
Thus, myeloid cells isolated from the brain tissue of neo-
natal mice had increased upregulation of some of the
same proinflammatory genes that were upregulated in
the whole brain, indicating that these cells were likely
contributing to the increased neuroinflammatory re-
sponse in neonatal mice.
Interestingly, analyses of Tlr4 and Tlr9 mRNA expres-
sion in the myeloid cell fractions indicated no significant
difference in Tlr4 mRNA expression in the myeloid frac-
tion from neonatal and weanling mice, while a slight
increase in Tlr9 mRNA was observed in weanlings
(Figure 6E-F). Thus, the difference in the cytokine re-
sponse between neonatal and weanling myeloid cells did
not correlate with differences in TLR mRNA expression.
Differences in the myeloid cell populations in the brains
of neonatal and weanling mice
Since RNA analysis of myeloid cells from neonatal and
weanling mice indicated differences in their neuroin-
flammatory responses, we further analyzed these cells by
flow cytometry at 6 hpi, the time point that mRNAdifferences were observed. Analysis of cells expressing
leukocyte common antigen CD45 and the myeloid-
specific marker CD11b identified four distinct cell popula-
tions. These included CD45lo, CD11blo microglia (mic,
dark blue gate), and three populations of CD45hi cells that
varied in their expression of CD11b (light blue, green and
fuchsia gates) (Figure 7). Further analysis using the inflam-
matory monocyte marker Ly6C indicated that these three
cell populations were either Ly6C +monocytes (m1 green
and m2 fuchsia gates) or Ly6C− resident macrophages
(mac, light blue gate). The monocyte populations have
two distinct profiles in the weanling mice which differed
in the expression of CD11b and F4/80, being either
CD11bint, F4/80hi (m1, green gate) or CD11bhi and F4/80lo
(m2, fuschia gate). Lower numbers of all cell populations
were observed in neonates compared with weanlings;
most notably, the microglia population (mic, dark blue
gate) had five-fold fewer cells in neonates than weanlings
(Figure 7). In addition, microglia had higher levels of
F4/80 (middle panel, X axis) compared with weanlings in-
dicating that these cells change phenotypically between
these two ages. Of the CD45hi populations, the resident
macrophage (mac, light blue gate) was also reduced in ne-
onates and was barely detectable.
Figure 7 Differences in the microglial and resident macrophage populations in the CNS of neonatal and weanling mice. Cells from
weanling (A) and neonatal (B) mice at 6 hpi with LPS were isolated on Percoll gradients and the myeloid cell fraction was collected from the
30/70% interface and analyzed by flow cytometry. An initial gate was drawn based on forward and side scatter to exclude cellular debris and
doublets. This cell fraction was further gated on only CD45+ and CD11b + cells to directly analyze the myeloid cells. The CD45+ CD11b + cells were
subsequently divided into subpopulations based on their relative expression of CD11b and CD45. These included a CD45lo, CD11b +microglial
population (dark blue gate) and three populations of CD45hi cells: CD11blo (light blue), CD11bint (green) and CD11bhi (fuchsia). These populations
were then analyzed using CD45 and F4/80 or CD45 and Ly6C to identify resident macrophage and monocyte populations. Data are representative
of 4 to 5 mice per group.
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examined cell surface markers related to cell activation:
CD11a (integrin α L) and CD86; as well as those associ-
ated with inhibition of activation: CD200R (OX2R) and
CD172a (SIRPα) [34-37]. Cells were analyzed at 6 hpi,
that is, at the peak of cytokine mRNA expression. A sig-
nificant difference was observed between neonatal and
weanling mice in the mean fluorescent intensity (MFI)
for these molecules (Figure 8), although the relative sur-
face expression of these molecules was not altered by
LPS stimulation (data not shown). Neonatal microglia
had higher levels of CD11a and CD172a, but lower levels
of CD86 (Figure 8). Neonatal monocytes had lower
levels of CD11a than weanling monocytes, with varying
levels of CD86, CD200R and CD172a depending on the
subpopulation (Figure 8). Thus, there were distinct dif-
ferences in the expression of cell surface regulatory
markers between neonates and weanlings, but these var-
ied substantially between the cell populations.SLAMF7 is expressed at high levels in neonatal microglia
Slamf7 was one of the markers whose mRNA expression
was upregulated in whole brain tissue and in the
myeloid/immune cells fraction from neonatal mice
(Figure 5G, Figure 6C). SLAMF7 is often used as an acti-
vation marker for NK cells [31,32,38], however, we were
unable to detect NK cells in the CNS by flow cytometry
(data not shown). Although SLAMF7 was recently de-
tected on activated human monocytes [39], expression
in the CNS has not been reported. Analysis of SLAMF7
on the myeloid cells in the CNS demonstrated clear ex-
pression of SLAMF7 on neonatal microglia and lower
levels of SLAMF7 on weanling microglia (Figure 9A),
but was not upregulated following LPS stimulation
(Figure 9B). SLAMF7 was not expressed at levels above
background on the monocyte or macrophage population
(Figure 9C, data not shown) for either PBS or LPS inoc-
ulated mice. Thus, SLAMF7 appears to be primarily































































Figure 8 Neonatal versus weanling expression of activating and inhibitory markers on microglia. Cells shown in Figure 7 were
additionally analyzed for expression of activation markers CD11a (A) and CD86 (B) as well as inhibitory markers CD200R (C) and CD172a (D).
Mean Fluorescent Intensity (MFI) of microglia (CD45lo, CD11blo dark blue gate in Figure 7) and both monocyte populations are shown. Monocyte
1 population contained cells that were CD11bint, F4/80hi, Ly6C + (green gate in Figure 7) while monocyte 2 population contained cells that were
CD11bhi, F4/80lo, Ly6C + (fuchsia gate in Figure 7). Resident macrophages (light blue gate in Figure 7) were not analyzed since there were not
sufficient cells in the neonatal cell population for comparison. No difference was observed between the PBS and LPS treated groups for any
marker (data not shown). Data are the mean ± SEM for 3 mice per group. Data were similar from two experiments, although different antibody
concentrations were used in the second experiment (not shown). Statistical analysis was completed by two-way analysis of variance with Tukey’s
multiple comparisons test. Significant age-specific differences are as indicated: *P < 0.05, **P < 0.01, ***P < 0.001.
Christensen et al. Journal of Neuroinflammation 2014, 11:70 Page 9 of 13
http://www.jneuroinflammation.com/content/11/1/70marker for identifying this population. The higher ex-
pression of SLAMF7, CD11a, F4/80 and CD172a on
neonatal microglia compared with weanling microglia
indicates a clear phenotype on these cells that correlates
with the heightened inflammatory response in the CNS.
Discussion
In the current study, we observed heightened responses
to TLR stimulation in the CNS in neonatal mice com-
pared with weanlings. This response was most notable
with LPS, but was also observed with CpG-ODNs.
Kinetic analysis of gene expression indicated that the
increased cytokine response in neonates peaked at 6 hpi,
which was associated with an increase in activation
markers for myeloid cells in the CNS. Analysis of this
cell population in the brains of neonatal and weanling
mice indicated two primary differences in the myeloid
population between these ages. The first was more mac-
rophages in weanling mice and the second was increased
expression of multiple regulatory molecules on neonatal
microglia. Surprisingly, SLAMF7, a regulatory molecule
on NK cells [32,38], was detected on neonatal, microglia
and the mRNA expression of this molecule tightly corre-
lated with cytokine induction.
The increased cytokine expression following TLR
stimulation in neonates in the brain is opposite of theactivation of monocytes/macrophages in the periphery.
For example, neonatal mouse monocytes/macrophages
have reduced cytokine responses to TLR4 stimulation
compared with adults, with the exception of IL-10 pro-
duction [40,41]. Similar age-related effects were also ob-
served in studies with human monocytes/macrophages
[12,16,18,19]. The primary reason for the differences in
the periphery compared with the CNS may simply be
the requirement for microglia in the CNS to be active in
neonates for synaptic pruning and other developmental
processes. A similar role in development has not been
reported for peripheral monocytes. Thus, unlike adult
animals in which the immune response in the CNS is
considered to be more limited than in peripheral tissues,
the CNS in neonatal mice may be more responsive to in-
sult or injury and produce a more substantial inflamma-
tory response. Since development of the neonatal mouse
brain corresponds in several parameters with the second
trimester development of the human brain [10,42], this
time period in humans may be particularly sensitive to
immune stimulation. However, since myeloid cells ap-
pear to be responsible for this increased inflammatory
response, the inflammatory response in the human brain
will most likely correlate with the timeframe in which
these cells are most active during development, which












Figure 9 SLAMF7 is strongly expressed by neonatal microglia. Cells were isolated as described in Figure 7. (A) SLAMF7 expression on
microglia cells (dark blue gate in Figure 7) from an LPS-inoculated neonatal mouse (black line) or weanling mouse (gray line). Light gray line
is from a sample that did not contain the anti-SLAMF7 antibody (no antibody negative control). Plots shown are from a single mouse but are
consistent with data from 2 to 4 mice per age. (B) Average MFI of SLAMF7 expression on microglia cells from PBS or LPS-treated mice showing
a higher level of SLAMF7 on neonatal microglia. Data are the mean ± SEM for 3 LPS-treated mice per group at 6 hpi. Only two data points are
plotted for PBS-treated controls and thus represent a range of data rather than SEM. Data are representative of two replicate experiments,
although different antibody concentrations were used in the second experiment (not shown). ***P < 0.001 for direct comparison of LPS-treated
groups (C) SLAMF7 expression was not detected on the monocyte populations (combined cells from green and fuchsia gates in Figure 7)
when compared with the negative (no antibody) control (light gray line).
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the neonatal CNS is surprising considering the lower
level of Tlr mRNA expression and the higher levels of
inhibitory molecules, including CD200R and CD172a
(Figure 4, Figure 8). Deficiency in CD200R has been
linked to increased inflammation in models of experi-
mental autoimmune encephalitis (EAE) and Parkinson’s
disease [43,44], while CD172a negatively regulates
CD11b-mediated adhesion, migration and phagocytosis
[35,45]. The higher expression of these receptors would
predict a reduced responsiveness to TLR stimulation.
However, the functional ability of CD172a and CD200R
to inhibit myeloid cell activation may be dependent
on many factors, including expression of their ligands,
CD47 and CD200 respectively, on surrounding cells, as
well as the expression of signaling molecules necessary
to mediate inhibition of activation. Thus, the expression
of these receptors may not be sufficient to diminish the
inflammatory response to TLR stimulation in the neo-
natal brain.
The presence of SLAMF7 on neonatal microglia may
be an additional negative regulator of microglia activa-
tion. SLAMF7 is a self-ligand and is involved in both
cell activation as well as cell inhibition for NK cells
[32]. However, analysis of activated human monocytesindicated that these cells did not express EAT-2, which
is required for SLAMF7-induced activation [39]. SLAM
F7 inhibited MAPK activity of monocytes [39], suggest-
ing that SLAMF7 may function as a negative regulator
of myeloid cell activation. It is possible that SLAMF7
may function in a manner similar to CD200R or CD172a
and play a critical role in controlling the function of
microglia and their interactions with neurons in the de-
veloping brain.
In addition to the elevated expression of negative regu-
lators, neonatal microglia also had higher levels of integ-
rins, including CD11a and CD11b. CD11b may be
involved in TLR4 signaling by influencing the recruit-
ment and degradation of intracellular TLR signaling
adaptor proteins [46,47]. Therefore, elevated microglial
CD11b levels could alter TLR4 signaling in neonatal
microglia, resulting in the elevated cytokine responses
observed in the CNS of neonatal mice.
The ratio of the Ly6ChiCD11bhiF4/80lo monocytes
(m2, fuschia gate) relative to the other three myeloid cell
populations was higher in neonates than in weanling
mice, although the relative number of cells m2 was com-
parable between age groups (Figure 7). The increased ra-
tio of this cell population may indicate that this cell
population is a contributor to the inflammatory response
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three cell populations could influence the inflammatory
response if these cells had a regulatory role in limiting
inflammation through the production of anti-inflamma-
tory cytokines or inhibitory molecules. We did not ob-
serve any increase in IL-10 production in the weanling
brain compared with the neonatal brain, indicating that
these macrophages were not alternatively activated mac-
rophages (data not shown). However, we cannot rule out
localized production of inhibitory cytokines by these
cells that would limit microglial or monocyte activation
and cytokine production.
One of the few cytokines that was elevated in the
weanling brain compared with the neonatal brain was
Csf2 (GMCSF) a cytokine known to be involved in the
activation and maintenance of microglia and macro-
phages [48]. This induction of Csf2 mRNA could be due
to the higher percentages of the monocyte/macrophage
populations in the weanling mice. Additionally, quies-
cent microglia may be programmed to produce more
GMCSF upon stimulation to support cell activation and
proliferation, while the neonatal amoeboid microglia are
already in a heightened activation state.
Our studies indicate that myeloid cells are at least par-
tially responsible for the increased proinflammatory re-
sponse observed in neonates. However, other cell types
including endothelia, oligodendroglia, neurons and as-
trocytes may also contribute to the differences in the
cytokine production. Astrocytes have also been shown to
produce cytokines in response to TLR stimulation, in-
cluding TLR4 [28,49,50]. Astrocytes also undergo devel-
opmental changes in the first few weeks of birth,
including morphological changes and gene expression
[51,52], which may influence their response to TLR
stimulation. Interestingly, Gfap mRNA expression, a
marker of astrocyte activation, was lower in neonates
compared with weanlings (Figure 5D). Thus, astrocytes
may contribute to the neuroinflammatory response in
both weanlings and neonates, but are unlikely to be a
major source of the increased cytokine response in
neonates.
Conclusions
Although elevated levels of IL-6, IL-1β and TNF in the
neonatal brain have been correlated with later cognitive
disability and behavioral changes [7], few published stud-
ies directly compare the neuroinflammatory response of
neonates with that of older animals. In our studies, we
demonstrate that neonates have an altered neuroinflam-
matory response to TLR stimulation compared with
older animals. The stronger response of myeloid cells to
TLR stimulation following insult or injury to the CNS
may have severe consequences in the neonate. Microglial
production of soluble factors influence neuronal cellmaturation and apoptosis and can affect neuroprogeni-
tor proliferation and differentiation [20,22,53,54]. Stimu-
lation via TLR4 alters the activation state of these cells
as observed by the strong cytokine responses and Nos2
mRNA expression (Figure 1, Figure 2). Thus, increased
microglial activation may significantly alter brain develop-
ment resulting in the long-term damage that has been as-
sociated with neonatal insults to the brain. Understanding
the factors that regulate this distinct neuroinflammatory
response will be important in preventing long-term dam-
age following infection in the neonatal brain.
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